Human cell lines established from biliary tract cancers are rare, and only five have been reported previously. We report the characterisation of six new six biliary tract cancer cell lines (designated SNU-245, SNU-308, SNU-478, SNU-869, SNU-1079 and SNU-1196) established from primary tumour samples of Korean patients. The cell lines were isolated from two extrahepatic bile duct cancers (one adenocarcinoma of common bile duct, one hilar bile duct cancer), two adenocarcinomas of ampulla of Vater, one intrahepatic bile duct cancer (cholangiocarcinoma), and one adenocarcinoma of the gall bladder. The cell phenotypes, including the histopathology of the primary tumours and in vitro growth characteristics, were determined. We also performed molecular characterisation, including DNA fingerprinting analysis and abnormalities of K-ras, p15, p16, p53, hMLH1, hMSH2, DPC4, b-catenin, E-cadherin, hOGG1, STK11, and TGF-bRII genes by PCR -SSCP and sequencing analysis. In addition, we compared the genetic alterations in tumour cell lines and their corresponding tumour tissues. All lines grew as adherent cells. Population doubling times varied from 48 -72 h. The culture success rate was 20% (six out of 30 attempts). All cell lines showed (i) relatively high viability; (ii) absence of mycoplasma or bacteria contamination; and (iii) genetic heterogeneity by DNA fingerprinting analysis. Among the lines, three lines had p53 mutations; and homozygous deletions in both p16 and p15 genes were found three and three lines, respectively; one line had a heterozygous missense mutation in hMLH1; E-cadherin gene was hypermethylated in two lines. Since the establishment of biliary tract cancer cell lines has been rarely reported in the literature, these newly established and well characterised biliary tract cancer cell lines would be very useful for studying the biology of biliary tract cancers, particularly those related to hypermethylation of E-cadherin gene in biliary tract cancer.
The prognosis of patients with biliary tract cancer is poor despite recent advances in diagnostic and therapeutic techniques (Yamada et al, 1995; Yoshida et al, 1995) . An understanding of the biological nature of this neoplasm is needed to improve the prognosis of these patients. For this purpose, a permanently growing cell line can be the most suitable tool because it is applicable to a variety of experiments, including the understanding of tumour biology (Yano et al, 1992; Yamada et al, 1995) . However, biliary tract cancer cell lines are very rare, a total of 13 cell lines have been reported in the literature. Gene alterations involving in carcinogenesis and cancer progress in the cancers of alimentary tract such as colorectal cancer and pancreatic cancer have been known. However, in biliary tract cancers, few reports have shown genetic changes responsible for oncogene and tumour suppressor gene (Yoshida et al, 1995) . In the present study, we report the establishment and characterisation of six new human biliary tract cancer cell lines (designated SNU-245, SNU-308, SNU-478, SNU-869, SNU-1079 and SNU-1196). We described cell phenotypes including the in vivo and in vitro growth characteristics, and DNA profiles for authenticity of each line. We also checked genetic alterations of K-ras, p15, p16, p53, hMLH1, hMSH2, DPC4, STK11, E-cadherin, hOGG1, TGF-bRII genes and compared the genetic alterations in tumour cell lines and their corresponding tumour tissues. In these biliary tract cancer cell lines, the methylation status of promoter region in E-cadherin gene was also investigated by 5-aza-2'-deoxycytidine treatment and methylation specific-polymerase chain reaction (MS-PCR) after sodium bisulphite treatment.
MATERIALS AND METHODS

Cell culture
Cell lines were established from pathologically proven primary biliary tract and ampulla of Vater cancer samples of six Korean patients. Of these, two cancer cell lines originated in extrahepatic bile duct cancer, one in intraheatic bile duct cancer, and one in adenocarcinoma of gall bladder, and two in ampulla of Vater cancer. Solid tumours were finely minced with scissors and disassociated into small aggregates by pipetting. Appropriate amounts of finely minced neoplastic-tissue fragments were seeded into 25 cm 2 flasks. Tumour cells were initially cultured in ACL-4 medium supplemented with 5% heat-inactivated foetal bovine serum (AR5) (Park et al, 1987 . After establishment, cultures were maintained in RPMI 1640 supplemented with 10% heatinactivated foetal bovine serum. If stromal-cell growth was noted in initial cultures, differential trypsinisation was used to obtain a pure tumour-cell population. Cultures were maintained in humidified incubators at 378C in an atmosphere of 5% CO 2 and 95% air. A-431, HeLa, and K-562 cell lines from the American Type Cell Culture (ATCC) and SNU-1 cell line from Korean Cell Line Bank (KCLB) were used for PCR controls. For growth properties and morphology study in vitro, population doubling times and cell viability were determined and cells grown on 75-cm 2 culture flasks were observed daily by phase-contrast microscopy .
Nucleic acid isolation, cDNA synthesis and DNA profiles Genomic DNA and total RNA were isolated from washed-cell pellets. cDNA was synthesised according to the manufacturer's specifications (Power cDNA synthesis kit; Intron Biotechnology, Seoul, Korea) using 2 mg of total RNA. To compare the genetic alterations between established tumour cell lines and their corresponding tumour tissues, we obtained DNAs from microdissected tumour cells and stromal cells in H&E stained slides of corresponding tumour tissues of each tumour cell line. Approximately 500 -1000 dissected tumour or stromal cells were digested using proteinase K method described previously (Hung et al, 1995) . For DNAprofile analysis, DNA was amplified by PCR at loci containing highly polymorphic microsatellite markers: D1S1586 and D3S1765 (Ku et al, 1999) .
Mutation screening in K-ras, p53, p15, p16, hMLH1 and hMSH2 genes Mutation screening of exons 1 and 2 of K-ras was performed by DNA sequencing analysis using oligonucleotide primers as previously described (Capon et al, 1983) . Mutational screening of exons 5 to 8 of p53 was performed by PCR-based single strand conformation polymorphism (PCR-SSCP) analysis . Primers for PCR-SSCP for exons 1 and 2 of the p15 gene were synthesised (Orlow et al, 1995) , and PCR-SSCP primers for exons 1 and 2 of p16 gene were carried out as described previously (Williamson et al, 1995) . For deletion analysis of the p15 and p16 genes, we amplified the exons of each gene without [a- 32 P]-dCTP. To investigate the genetic status of hMSH2 and hMLH1 genes in biliary tract cancer cell lines, PCR-SSCP analysis was used to screen mutations (Liu et al, 1994; Han et al, 1996) .
Mutation screening in b-catenin, DPC4, STK11, TGF-bRII, and hOGG1 genes PCR-SSCP analysis to screen mutations of the b-catenin gene was carried out by designed-primers for amplification of exons 3, 5, and 6, since mutations reported earlier in the b-catenin gene are concentrated at these exons (Kitaeva et al, 1997; Iwao et al, 1998) . To investigate the genetic alteration of the DPC4 gene, we screened 11 exons by PCR-SSCP (Hahn et al, 1998) . For mutational analysis of STK11 gene, the PCR primer pairs were used as described previously (Jenne et al, 1998) . Mutation screening of the full seven exons of TGF-bRII gene was also performed by PCR-SSCP analysis (Lu et al, 1996) . For mutational analysis of hOGG1 gene, PCR primer pairs and conditions were described previously (Kohno et al, 1998) .
Genetic alteration and methylation analysis of E-cadherin gene
To investigate mutation, all 16 exons were screened by PCR-SSCP (Berx et al, 1996) . For determination of the methylation status in E-cadherin gene, 5-aza-2'-deoxycytidine treatment and sodium bisulphite modification were employed. For 5-aza-2'-deoxycytidine treatment, cells were seeded at 2610 5 cells 75-cm 2 culture flask on day 0. The cells were treated with 10 mm 5-aza-2'-deoxycytidine for 24 h on days 2 and 5. The medium was changed 24 h after adding 5-aza-2'-deoxycytidine. Cells were harvested on day 8 for analysis of E-cadherin expression.
For mRNA expression analysis, cDNA was amplified in a 25 ml PCR reaction using 0.75 ml of the reverse-transcription reaction, the primers and 0.5 units of the Taq DNA polymerase. Both Ecadherin and b-actin RT -PCR reactions used the same cDNA synthesis. b-actin was amplified to control for RNA integrity. The primers for the amplification of E-cadherin gene mRNA were described previously (Melki et al, 2000) . Products were electrophoresed on a 2% agarose gel with ethidium bromide.
The sodium bisulphite reaction was carried out for 16 h at 558C. Following bisulphite modification, the DNA was ethanol precipitated, dried, and resuspended in 100 ml distilled water. A nested PCR was performed using the nested PCR primers as described previously (Melki et al, 2000) .
Cloning and sequencing
Samples showing abnormal bands by SSCP were subjected to DNA sequencing analysis. Fresh PCR products were ligated into PCR TM II vectors and subcloned using the TA cloning system (Invitrogen, San Diego, CA, USA). A minimum of 10 individual clones were then pooled and used for DNA isolation. Bi-directional DNA sequencing analysis performed by using dideoxy chain termination method with a T7 DNA polymerase sequencing kit (Pharmacia Biotech Inc., Piscataway, NJ, USA), or directly sequenced using a Taq dideoxy terminator cycle sequencing kit on an ABI 377 DNA sequencer (Perkin-Elmer, Foster City, CA, USA).
RESULTS
Culture characteristics
Population doubling times ranged 48 to 72 h, and cell viability ranged from 85 to 94% (Table 1 ). All the cell lines were free of contamination with either bacteria or Mycoplasma. The culture success rate was 20% (six out of 30 attempts).
Morphologic studies
Six carcinoma cell lines derived from biliary tract system were established. The primary tumour of SNU-245 originated from the distal common bile duct. Microscopically, the tumour was composed of well-formed glands lined by a few rows of highly atypical cuboidal cells with lumina containing oeosinophilic material or necrotic cell debris and infiltrated to the stroma. Cell line SNU-308 was established from an adenocarcinoma of a gall bladder. Microscopically, the tumour was composed of well-differentiated neoplastic glands or trabeculae. Two cases of ampulla of Vater carcinoma were obtained from primary tumours. Microscopically, the tumour of SNU-478 was poorly differentiated adenocarcinoma with signet ring cell feature and infiltrated to the pancreas along the interstitial space as a single cell or cell cords. The tumour of SNU-869 was composed of well differentiated adenocarcinoma with focal papillary feature. Five out of 10 periduodenal lymph nodes were involved by this tumour and the tumour infiltrated to the duodenal muscle layer and involved of distal common bile duct. The case of SNU-1079 was obtained from the cholangiocarcinoma arising from right lobe of liver. Microscopically, the tumour of SNU-1079 was composed of irregular nests of tumour cells with focal glandular differentiation, which were separated by fibrous stroma. Cell line SNU-1196 was derived from Klatskin tumour arising in the hepatic duct confluence and invaded to the both intrahepatic duct and common bile duct. Tumour cells had large and vesicular nuclei, and micro or macronucleoli.
In culture, all the cell lines except SNU-478 grew as monolayer of substrate-adherent cells. SNU-245 exhibited trabecular arrangement with acinar formation ( Figure 1A ). Tumour cells of SNU-308 was composed of polygonal and relatively uniform cells having large, round to ovoid, vesicular nuclei with prominent nucleoli. Acinar formation was focally seen ( Figure 1B 
DNA profiles
DNA profiles using two highly polymorphic microsatellite markers (D1S1586 and D3S1765) showed that six biliary tract carcinoma cell lines are unique and unrelated (Figure 2) . These results help exclude the possibility of cross-contamination between the cell lines, as well as by HeLa cell line.
Mutations in the p53, p15, p16 and hMLH1 genes For p53 gene, SNU-478 had an adenine insertion at codon 266 of exon 8 resulting in a premature stop codon (TGA) at 12 bp downstream (Figure 3 ): SNU-869 harboured a missense mutation from aspartic (GAC) acid to glycine (GGT) at codon 48 of exon 4; SNU-1196 had a missense mutation from asparagine (CGT) to cysteine (TGT) at codon 273 of exon 8. A summary of the results appears in Table 2 .
There were no band shifts in p15 and p16 genes by PCR-PCR SSCP analysis. However, there were no PCR amplifications in three lines (SNU-478, SNU-1079, and SNU-1196) . By based deletion analysis of each gene, we found that exon 1 of p15 gene was not amplified in three cell lines (SNU-478, SNU-1079 and SNU-1196) and exon 2 of this gene was not amplified in two cell lines (SNU-478 and SNU-119). We also found that exons 1 and 2 of p16 gene were not amplified in three cell lines (SNU-478, SNU-1079 and SNU-1196) (Figure 4) . The results were listed (Table 2) .
In hMLH1 mutational analysis, only SNU-478 harboured a heterozygous missense mutation from GAT to GTT at codon 384 of exon 12, with resultant amino acid change from aspartic acid to valine (data not shown).
Mutation analysis in b-Catenin, DPC4, hOGG1, STK11, and TGF-bRII genes There were no abnormal band shift bands in the b-catenin, DPC4, STK11, and TGF-bRII genes by PCR-SSCP analysis. In hOGG1 gene, 4 lines (SNU-308, SNU-478, SNU-869 and SNU-1079) were found to harbour abnormal band shift bands in exon 5. By the direct sequencing of DNA fragments corresponding to shifted bands, a C?G nucleotide change at 715 bp from exon 5 was found in all four lines (Table 2) .
mRNA expression and methylation analysis in E-cadherin gene
By PCR-SSCP for all 16 exons, abnormal band shifts were not found in all cases. To determine the expression of E-cadherin gene in six biliary tract cancer cell lines, we used RT -PCR analysis. SNU-1 and A-431 cell lines were used for negative and positive controls for the expression of E-cadherin mRNA. As shown in Figure 5 , SNU-245, SNU-308, SNU-869, SNU-1196 and control (A-431) cell lines expressed E-cadherin mRNA, whereas SNU-478, SNU-1079 and control (SNU-1) cell lines showed absence of expression ( Figure 5A ). Therefore, we determined the methylation status by 5-aza-2'-deoxycytidine treatment and sodium bisulphite modification in these cell lines. After 5-aza-2'-deoxycytidine treatment, E-cadherin mRNA was reexpressed in SNU-478, SNU-1079 and control (SNU-1) cell lines ( Figure 5B ). Methylation specific PCR analysis for CpG island of promoter region in the E-cadherin gene after sodium bisulphite modification, DNA fragments were amplified in only SNU-478, SNU-1079 and SNU-1 cell lines ( Figure 5C ).
Comparison of genetic alterations in tumour cell lines and their corresponding tumour tissues
Of six biliary tract cancer cell lines, paraffin blocks from four cell lines (SNU-245, SNU-308, SNU-869 and SNU-1079) were available. Tumour cells and stromal cells were dissected, respectively, and DNAs were extracted from these samples. Genetic alterations in DNA of tumour cells were identical to those that had found in tumour cell lines and there were no mutations in constitutional DNAs (data not shown).
DISCUSSION
Advances in cell culture methods have made it possible to establish a variety of human carcinoma cell lines from surgical and autopsy tissues, peritoneum effusion, and biopsy specimens (Yano et al, 1992; Yamada et al, 1995) . Moreover, because pure cells in cultures can be used for a variety of studies that cannot be carried out using tissue specimens, the study of permanent cell lines established form human cancers has played a major role in our understanding of the biology of cancers. However, cell lines originated from biliary tract cancers have rarely been reported. Ten human extrahepatic bile duct carcinoma cell lines (SK-ChA-1 (Knuth et al, 1985) , KMBC (Yano et al, 1992) , and OCUCh-LM1 (Yamada et al, 1995) , TFK-1 (Saijyo et al, 1995) , ICBD-1 (Takiyama et al, 1998) , HBDC (Jiao et al, 2000) , SCK, JCK, Cho-CK, Choi-CK (Kim et al, 2001a) ) and three gall bladder carcinoma cell lines (MZ-ChA-1 and MzChA-2 (Knuth et al, 1985) , OCUG-1 (Yamada et al, 1997) have been reported in the world literature.
Molecular and Cellular Pathology
In this paper, we present six newly established biliary tract cancer cell lines derived from histopathological varied primary carcinomas including a distal common bile duct, gallbladder, two ampulla of Vater, an intrahepatic duct, and a hepatic duct bifurcation tumour. The culture success rate of 20%, reflecting the relative high efficiency of AR5 medium in selective growth of human biliary tract cancers, although the establishment of cell lines from biliary tract cancers, especially cell lines from primary tumours, is very difficult as described above.
Primary tumours revealed morphological heterogeneity including cellular and a growth pattern of original tumours in each tumour type. Cell lines derived from primary biliary tract cancer showed marked heterogeneity in cellular and nuclear morphology, and growth pattern in vitro. All six cell lines grew as adherent monolayer, of these, SNU-869 formed prominent domes.
In biliary tract cancers, the role of p53 is still controversial and mutation rate of this gene varied from 33 to 65% according to Figure 2 DNA fingerprinting analysis of biliary tract cancer cell lines using highly polymorphic microsatelilte markers. Lane numbers 1 to 8 show cell lines SNU-245, SNU-308, SNU-478, SNU-869, SNU-1079, SNU-1196, HeLa, K-562, and water only. It is evident that each of the six SNU biliary tract cancer cell lines is unique and unrelated.
PCR-SSCP exon 8
Normal SNU-245 anatomical site of the biliary tract. In gallbladder carcinomas from Korean, it was reported that 35.7% had mutations in this gene (Kim et al, 2001b) . In newly established six cell lines, we detect two missense mutations and one frameshift mutation (50%). Two mutations were found to be in exon 8 and one mutation in exon 4. p15 and p16 genes belonging to the cyclin-dependent kinase 4 inhibitory family, have homology and are adjacent to each other. In our six cell lines, simultaneously homozygous deletions of p15 and p16 genes, but no point mutation, were found in (SNU-478, SNU-1079 and SNU-1196) . In SNU-1079, exon 1 of p15 gene was deleted and exon 2 was intact. These results indicate that p15 and p16 are homozygously deleted preferentially in the region neighbouring the two genes in biliary tract cancer cell lines. Kim et al (2001) reported that 30.7% of this gene was mutated in gall bladder carcinomas from Korean. Moreover, the high frequency of deletions of p15 and p16 in cell lines indicate the possibility of these genes functioning as tumour suppressor genes in biliary tract cancer as described previously (Yoshida et al, 1995) .
We also found one heterozygous missense mutation at codon 384 of exon 12 in hMLH1 gene in one cell line (SNU-478). We screened the microsatellite instability (MSI) status in this line using several MSI markers such as BAT-25, BAT-26 and BAT-40 which were used as a surrogate to indicate MSI status, but failed to find evidence of MSI (Myeroff et al, 1995) . Although we didn't check this mutation in normal counterpart because of no availability normal tissue, we think that this mutation is polymorphism because this cell line did not show MSI.
A significant number of human carcinomas and cancer cell lines lose sensitivity to negative growth regulation by transforming growth factor b (TGF-b) (Vincent et al, 1997) . In biliary tract cancers, it was reported that 16% (five out of 32 primary biliary carcinomas) had point mutations in the DPC4 gene (Hahn et al, 1998) . In our cell lines, we had not found shifted bands in all samples by PCR-SSCP analysis. Moreover, we found that all cell lines expressed intact DPC4 mRNA (data not shown). In addition, we did not find genetic alterations in TGF-bRII gene by PCR-SSCP and RT -PCR analysis, although genetic alterations of the TGF-bRII gene in biliary tract cancers have been reported Table 2 Abnormalities of the p15, p16, p53, K-ras, hMLH1, E-cadherin, hOGG1, b-catenin, DPC4, STK11 and TGF-bRII genes in SNU biliary tract cancer cell lines WT=mutations was not detected. 5-aza=RT -PCR after 5-aza-2'-deoxycytidine treatment. MS-PCR=methylation specific PCR. +=expression. 7=no expression. In the p15 gene, the exon 1 was only detected in SNU-1079 cell line. Mutations were not detected in K-ras, b-catenin, DPC4, STK11 and TGF-bRII genes. in some (Goggins et al, 1998; Yazumi et al, 2000) . We think that our results in six cancer cell lines do not relfect differences in genetics of biliary tract cancers in Korean because the sample size is too small, although we did not found any reports about mutations of DPC4 and TGF-bRII genes in biliary tract cancers in Korean. E-cadherin gene on chromosome 16q22.1 encodes a protein product important in the maintenance of the epithelial phenotype mediated by a Ca 2+ -dependent, homotypic cell -cell adhesion. The gene has been termed a 'metastasis suppressor' gene, because the Ecadherin protein can suppress tumour cell invasion and metastasis. E-cadherin gene expression is reduced or silenced in carcinomas of the breast and liver and many cell lines including those from colon, stomach, and prostate (reviewed by Melki et al, 2000) . Alterations in DNA methylation patterns are commonly found in essentially all cancers, often with concomitant changes in gene expression. In our study, we have not found mutations in all 16 exons of E-cadherin gene by PCR-SSCP. However, we found that E-cadherin gene expression was silenced in two cell lines (SNU-478 and SNU-1079) by RT -PCR analysis ( Figure 5A ). After demethylating agent (5-aza-2'-deoxycytidine) treatment, E-cadherin was successfully reexpressed in these two cell lines ( Figure 5B ). Hypermethylation of E-cadherin gene in two cell lines have also been confirmed by methylation specific PCR (MS-PCR) analysis ( Figure 5C ). These results would be the first report about hypermethylation of Ecadherin gene in biliary tract cancers.
Molecular and Cellular Pathology
Since the establishment of biliary tract cancer cell lines has been rarely reported in the literature, these well-characterised biliary tract cancer cell lines will be useful tools for investigating the biological characteristics of biliary tract cancer, especially those related to the hypermethylation of E-cadherin gene in biliary tract cancers.
